David Seftel
Papers
1
Total Citations
32
H-Index
1
About
David Seftel is a translational researcher whose work sits at the critical intersection of clinical diagnostics and high-throughput automation. His primary research areas include serological assay development, infectious disease epidemiology, and the deployment of robotic systems for large-scale public health screening. Seftel’s most notable contribution came during the COVID-19 pandemic, where he led the development of a sensitive and specific high-throughput, fully automated liquid-handling robotic system for detecting SARS-CoV-2 antibodies. This work, cited 32 times, addressed an urgent global need: as of July 2020, with over 14.7 million confirmed infections worldwide, scalable serological testing was essential for community screening, prevalence assessment, and identifying infected individuals. By integrating robotics with immunoassay protocols, Seftel’s system dramatically increased testing capacity while maintaining accuracy, enabling public health authorities to better track infection spread and antibody responses. His contributions exemplify how engineering solutions can directly enhance clinical laboratory capabilities during health emergencies. Seftel’s research continues to influence the design of automated diagnostic platforms, making him a key figure in modern pandemic preparedness and high-throughput clinical testing.
Research Focus
Key Achievements
Top Papers
- 1